LYCOS RETRIEVER 
Cardiology: Interventional Cardiology
built 146 days ago
Cardiology was one of the first clearly defined subspecialties to develop in pediatrics and the second to establish formal subspecialty board certification. During its existence, this discipline has seen extraordinary changes that are continuing at a rapid pace. The practice of pediatric cardiology is increasingly demanding. The cardiologist must continue to have excellent bedside skills as well as expertise in pharmacologic therapy, non-invasive imaging, cardiac catheterization and interventional cardiology, arrhythmia management, exercise physiology and post-operative care. In addition, progress and growth in a subspecialty is dependent upon active work in basic and applied research.
Source:
Research Activities: Each of the disciplines within Cardiology has its own research activity. The electrophysiologists participate in a number of multicenter trials evaluating new antiarrhythmic drugs, artificial pacemakers, and heart-rate variability as a predictor of prognosis in patients with coronary artery disease. They ... are active in investigating implantable cardioverter defibrillators. The physicians who practice interventional cardiology have participated for many years in the TIMI (Thrombolysis in Myocardial Infarction) trials, now initiating TIMI 13. The physicians also participate in studies related to coronary angioplasty. There are also ongoing studies of secondary prevention with cholesterol-lowering drugs in patients with coronary heart disease, and of Amlodipine in the treatment of congestive heart failure.
Source:
The Indian Society of Interventional Cardiology (ISIC) was formally launched on Wednesday, September 25, 2002, during the Transcatheter Cardiovascular Therapeutics (TCT) conference held here this week. ISIC has been formed to unite several thousand Interventional Cardiologists of Indian origin in a group "committed to providing educational, research, and training opportunities to its members."
Source:
"In this study, the incidence of stent thrombosis was 78 percent lower with the CYPHER Stent than with the Taxus Stent," said Principal Investigator Marie-Claude Morice, M.D., Head of Interventional Cardiology at the Institut Hospitalier Jacques Cartier, Massy, France. "As this is the first head-to- head trial to observe a difference in the rate of stent thrombosis, these results raise concerns and demand further investigation."
Source:
MORE ABOUT
Interventional Cardiology